|
Market Closed -
Nasdaq
01:30:00 23/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +2.55% |
|
+1.38% | -49.24% |
| 20/10 | Collegium Pharmaceutical Settles Nucynta Patent Litigation for $17 Million | MT |
| 09/10 | Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 75Cr | - | - | |||
| 1,16500Cr | |||||
| 64TCr | |||||
| 50TCr | |||||
| 38TCr | |||||
| 36TCr |
Select your edition
All financial news and data tailored to specific country editions
